Technical Analysis for KYMR - Kymera Therapeutics, Inc.

Grade Last Price % Change Price Change
B 37.21 2.34% 0.85
KYMR closed down 1.33 percent on Monday, January 30, 2023, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Boomer Buy Setup Bullish Swing Setup 2.34%
NR7 Range Contraction 2.34%
Inside Day Range Contraction 2.34%
Wide Bands Range Expansion 2.34%
Overbought Stochastic Strength 2.34%
Gapped Down Weakness 2.34%
Inside Day Range Contraction 0.98%
Wide Bands Range Expansion 0.98%
Overbought Stochastic Strength 0.98%
Outside Day Range Expansion 4.88%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 5 hours ago
Up 3% about 6 hours ago
10 DMA Support about 6 hours ago
Boomer Buy Entry about 6 hours ago
Rose Above Previous Day's High about 6 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Rheumatoid Arthritis Autoimmunity Hematologic Malignancies Dermatitis Atopic Dermatitis Hidradenitis Suppurativa

Is KYMR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 46.18
52 Week Low 13.15
Average Volume 785,308
200-Day Moving Average 25.62
50-Day Moving Average 29.37
20-Day Moving Average 31.97
10-Day Moving Average 35.57
Average True Range 2.15
RSI 64.66
ADX 33.65
+DI 27.36
-DI 11.88
Chandelier Exit (Long, 3 ATRs) 31.26
Chandelier Exit (Short, 3 ATRs) 30.49
Upper Bollinger Bands 40.70
Lower Bollinger Band 23.24
Percent B (%b) 0.75
BandWidth 54.63
MACD Line 2.44
MACD Signal Line 2.05
MACD Histogram 0.3907
Fundamentals Value
Market Cap 1.62 Billion
Num Shares 44.5 Million
Price-to-Sales 88.83
Price-to-Book 6.96
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.05
Resistance 3 (R3) 37.95 37.28 37.77
Resistance 2 (R2) 37.28 36.85 37.33 37.67
Resistance 1 (R1) 36.82 36.59 37.05 36.92 37.58
Pivot Point 36.16 36.16 36.27 36.21 36.16
Support 1 (S1) 35.70 35.73 35.93 35.80 35.14
Support 2 (S2) 35.03 35.46 35.08 35.05
Support 3 (S3) 34.57 35.03 34.95
Support 4 (S4) 34.67